False Claims Act Risks Relating to Federal Funding for Coronavirus (COVID-19) Relief

Summary

This practice note provides an overview of compliance obligations and False Claims Act risks to healthcare and life sciences companies arising out of three funding streams made available in response to the COVID-19 pandemic: (1) Medicare’s Advance Payment Program, (2) the Provider Relief Fund, and (3) the Paycheck Protection Program.